Isolated nail psoriasis may be a sign of psoriatic arthritis

NHS to Fund Ruxolitinib for Vitiligo

NICE has recommended topical ruxolitinib for facial non-segmental vitiligo in patients aged 12 or over after a revised cost review.

Lipedema Is Now Recognized as a Chronic Disease

International consensus defines lipedema as a chronic disease; clarifies its biology and diagnosis; and urges standardized care, research, and policy action.

Lilly's Zepbound and Taltz Improve Psoriasis Symptoms, Drive Weight Loss in Study

Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed ⁠better results in patients with the skin disease and obesity in a...

Bimekizumab Eases Plaque Psoriasis Symptoms Up to 3 Years

Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with bimekizumab vs secukinumab up to 3 years.

Amivantamab Tied to Diverse Dermatologic Events in NSCLC

Treatment with amivantamab is associated with a broad spectrum of dermatologic adverse events that can be severe in patients with non-small cell lung cancer, a real-world study shows.

Exploring Cutting-Edge Data for New and Emerging Treatments in Chronic Spontaneous Urticaria

Exploring Cutting-Edge Data for New and Emerging Treatments in Chronic Spontaneous Urticaria

Ask the Experts: The Latest Updates in the Pathophysiology and Targeted Treatment of Chronic Spontaneous Urticaria

Ask the Experts: The Latest Updates in the Pathophysiology and Targeted Treatment of Chronic Spontaneous Urticaria

Navigating Chronic Spontaneous Urticaria Diagnosis, Assessment, and Treatment Selection

Navigating Chronic Spontaneous Urticaria Diagnosis, Assessment, and Treatment Selection

Advancing Immune Checkpoint Inhibitor Use in Resectable Melanoma

Advancing Immune Checkpoint Inhibitor Use in Resectable Melanoma

Inside Idiopathic Inflammatory Myopathies (IIMs): From Pathophysiology to Presentation

Inside Idiopathic Inflammatory Myopathies (IIMs): From Pathophysiology to Presentation

From Clinical Suspicion to Classification of Idiopathic Inflammatory Myopathies (IIMs): Biomarkers and Diagnostic Best Practices

From Clinical Suspicion to Classification of Idiopathic Inflammatory Myopathies (IIMs): Biomarkers and Diagnostic Best Practices

From Unmet Needs to Targeted Intervention: Evolving Treatment Strategies in Idiopathic Inflammatory Myopathies (IIMs)

From Unmet Needs to Targeted Intervention: Evolving Treatment Strategies in Idiopathic Inflammatory Myopathies (IIMs)

AAD: American Academy of Dermatology

Collaborative Clinical Conversations: A Virtual Tumor Board Case Challenge on Immunotherapy in Resectable Melanoma

Collaborative Clinical Conversations: A Virtual Tumor Board Case Challenge on Immunotherapy in Resectable Melanoma

EADV: European Academy of Dermatology and Venereology

Dissolving Drug for Hereditary Angioedema Helps Young Kids

Rapid symptom relief and "excellent" safety reported in small phase III trial